CORRECTING and REPLACING Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group’s 340B Business to Omnicell

NEW YORK–(BUSINESS WIRE)–Headline of release should read: Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group’s 340B Business to Omnicell (instead of: Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group to Omnicell) The updated release reads: BLUE WOLF CAPITAL CLOSES ON SALE OF PHARMACEUTICAL STRATEGIES GROUP’S 340B BUSINESS TO OMNICELL PSG’s market-leading 340B Link business is being sold for $225 million nine years after Blue Wolf’s initial investment PSG bui